Clinical Trials Directory

Trials / Completed

CompletedNCT04583787

xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease

xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease (xSPECT MPI Study)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is to evaluate the feasibility of myocardial Standardized Uptake Volume (SUV) assessment by means of X- (Single photon emission tomography) SPECT/Computed tomography (CT), to assess normal reference value under rest and stress in a homogeneous population without Coronary Artery Disease (CAD) and to assess the variation of absolute quantitative SUV measurements under rest and stress. The values will be evaluated in comparison with perfusion Positron Emission Tomography (PET)/CT (using 82Rb as perfusion tracer) and CT coronary angiography (CTCA) with contrast medium.).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST99mTc-sestamibi myocardial perfusion SPECT82Rb-PET/CT with CT based coronary angiography (CCTA) as part of clinical care at Day 1
DIAGNOSTIC_TEST82Rb-Chloride myocardial perfusion PET with CCTAstress-rest 99mTc-sestamibi myocardial perfusion SPECT, performed subsequent to 99mTc-sestamibi myocardial perfusion SPECT at Day 2

Timeline

Start date
2021-12-07
Primary completion
2024-05-28
Completion
2024-05-28
First posted
2020-10-12
Last updated
2024-06-28

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04583787. Inclusion in this directory is not an endorsement.